Dr Premkumar Raja, MD | |
3415 Maccorkle Ave Se, Charleston, WV 25304-1334 | |
(304) 388-1790 | |
(304) 388-1795 |
Full Name | Dr Premkumar Raja |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 21 Years |
Location | 3415 Maccorkle Ave Se, Charleston, West Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689631442 | NPI | - | NPPES |
2006367000 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0001X | Radiology - Radiation Oncology | 21336 (West Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Charleston Area Medical Center | Charleston, WV | Hospital |
Thomas Memorial Hospital | South charleston, WV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Charleston Radiation Therapy Consultants Pllc | 4688579428 | 3 |
News Archive
Researchers led by engineers at Tufts University have developed a novel, significantly more efficient fabrication method for silk that allows them to heat and mold the material into solid forms for a wide range of applications, including medical devices.
A scientist at the La Jolla Institute for Allergy & Immunology has received one of the National Institutes of Health (NIH)'s top awards - the 2009 NIH Director's Pioneer Award. The prestigious prize carries with it funding for total costs of up to $4.7 million over five years, and is designed to support the work of exceptionally creative scientists, whose novel proposals offer the potential to make extraordinary contributions to human health.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
Scientists at the Gladstone Institutes have invented a new way to create three-dimensional human heart tissue from stem cells. The tissue can be used to model disease and test drugs, and it opens the door for a precision medicine approach to treating heart disease. Although there are existing techniques to make three-dimensional tissues from heart cells, the new method dramatically reduces the number of cells needed, making it an easier, cheaper, and more efficient system.
› Verified 5 days ago
Entity Name | Charleston Radiation Therapy Consultants Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942208145 PECOS PAC ID: 4688579428 Enrollment ID: O20031204000446 |
News Archive
Researchers led by engineers at Tufts University have developed a novel, significantly more efficient fabrication method for silk that allows them to heat and mold the material into solid forms for a wide range of applications, including medical devices.
A scientist at the La Jolla Institute for Allergy & Immunology has received one of the National Institutes of Health (NIH)'s top awards - the 2009 NIH Director's Pioneer Award. The prestigious prize carries with it funding for total costs of up to $4.7 million over five years, and is designed to support the work of exceptionally creative scientists, whose novel proposals offer the potential to make extraordinary contributions to human health.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
Scientists at the Gladstone Institutes have invented a new way to create three-dimensional human heart tissue from stem cells. The tissue can be used to model disease and test drugs, and it opens the door for a precision medicine approach to treating heart disease. Although there are existing techniques to make three-dimensional tissues from heart cells, the new method dramatically reduces the number of cells needed, making it an easier, cheaper, and more efficient system.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Premkumar Raja, MD Po Box 896158, Charlotte, NC 28289-6158 Ph: (304) 388-1790 | Dr Premkumar Raja, MD 3415 Maccorkle Ave Se, Charleston, WV 25304-1334 Ph: (304) 388-1790 |
News Archive
Researchers led by engineers at Tufts University have developed a novel, significantly more efficient fabrication method for silk that allows them to heat and mold the material into solid forms for a wide range of applications, including medical devices.
A scientist at the La Jolla Institute for Allergy & Immunology has received one of the National Institutes of Health (NIH)'s top awards - the 2009 NIH Director's Pioneer Award. The prestigious prize carries with it funding for total costs of up to $4.7 million over five years, and is designed to support the work of exceptionally creative scientists, whose novel proposals offer the potential to make extraordinary contributions to human health.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
Scientists at the Gladstone Institutes have invented a new way to create three-dimensional human heart tissue from stem cells. The tissue can be used to model disease and test drugs, and it opens the door for a precision medicine approach to treating heart disease. Although there are existing techniques to make three-dimensional tissues from heart cells, the new method dramatically reduces the number of cells needed, making it an easier, cheaper, and more efficient system.
› Verified 5 days ago
Matthew W. Morris, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1120 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-344-3457 Fax: 304-344-3480 | |
Dr. Mary H.l. Mcjunkin, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1120 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-344-3457 Fax: 304-344-3480 | |
Ravindra K Gogineni, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1021 Quarrier St, Ste 301, Charleston, WV 25301 Phone: 304-343-4625 Fax: 304-343-4626 | |
Dr. John F. Mega, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1120 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-344-3457 Fax: 304-344-3480 | |
Riad Al-asbahi, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1021 Quarrier St, Ste 301, Charleston, WV 25301 Phone: 304-343-4625 Fax: 304-343-4626 | |
Dr. Jennifer M. Smith, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1120 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-344-3457 Fax: 304-344-3480 | |
Timothy Aaron Vanhoose, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1120 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-344-3457 Fax: 304-344-3480 |